Zeng, Yi <br/><br/>
Induction of BCR-ABL-specific immunity following vaccination with chaperone-rich cell lysates derived from BCR-ABL+ tumor cells.  [electronic resource] 

 -  Blood  Mar 2005 
 - 2016-22 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood-2004-05-1915  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amino Acid Sequence<br/>Animals<br/>Cancer Vaccines--administration & dosage<br/>Cell Extracts--administration & dosage<br/>Cell Line, Tumor<br/>Dendritic Cells--immunology<br/>Fusion Proteins, bcr-abl--immunology<br/>Immunity<br/>Immunotherapy, Adoptive<br/>Interferon-gamma--metabolism<br/>Leukemia--immunology<br/>Mice<br/>Mice, Inbred BALB C<br/>Molecular Chaperones--physiology<br/>Neoplasm Transplantation<br/>Peptide Fragments--administration & dosage<br/>Spleen--cytology<br/>T-Cell Antigen Receptor Specificity<br/>T-Lymphocytes, Cytotoxic--immunology